Free shipping in 🇪🇺 from 90€
Menu
Speciality: Dr Garcia is a general practitioner also trained in the therapeutic use of psilocybin.
He adopts a holistic and integrative approach, also an expert in the microbiome.
Duration: 45-minute consultation.
Languages: English, Spanish, Dutch.
NB: By booking a meeting with Dr Garcia, you validate the medical consultation terms and conditions attached.
We advise against combining the two.
If you’re considering tapering off or are concerned about potential interactions with your medication, please consult our medical consultant, Dr. David Garcia Padron, or your own doctor.
Yes, multiple experts suggest it can be beneficial for people with ADHD or ADD, as microdosing improves focus and flow state.
Please speak with our medical consultant, Dr. David Garcia Padron, or your own doctor, especially if you are already undergoing treatment.
We recommend not combining Bien’s microdose with antibiotics due to insufficient information about their interaction.
If you choose to do so, always speak to your doctor first.
Alternatively, you can schedule an appointment with our resident medical consultant, Dr. David Garcia Padron, who can provide assistance.
We recommend not using Bien during pregnancy or breastfeeding.
However, it can be used for postpartum support (if you are not breastfeeding).
We offer a range of products, including those containing psilocybin, like PEACE in the Chaos, and others without psilocybin, containing only lion’s mane, such as FOCUS in the Chaos.
All our products provide benefits, but if you are hesitant about microdosing, we recommend starting with the FOCUS in the Chaos gummies.
Yes, truffle sales are legal in the Netherlands, where Bien Health is based, regardless of the dosage.
Bien can also ship its products within the EU. However, the rules and regulations of your country will apply once the shipment reaches you.
No, it’s actually the opposite.
The risk of addiction to psilocybin, the active ingredient in our microdose, is minimal at 0.2%. For comparison, the risk for SSRIs is 44%.
Ongoing research is currently exploring psilocybin as a potential treatment for substance use disorders. Nevertheless, it’s always important to monitor your relationship with it.
We ship within the European Union with a high success rate.
For our EU customers, we offer a delivery guarantee: if your order does not reach its destination, we will send you a new one.
